Innovative Product Launches Arbor Assays frequently introduces new ELISA kits targeting key biomarkers such as Thromboxane B2, TNF-alpha, BNP, and SARS-CoV-2 antibodies, indicating a steady pipeline of innovative products. This ongoing development presents opportunities to supply complementary reagents, kits, or automation solutions to streamline their testing processes.

Focus on Biomarker Research The company's specialization in biomarker detection across cardiovascular, infectious disease, and inflammatory markers suggests a strong need for high-quality reagents, assay plates, and automation tools tailored for biomarker analysis, offering potential for upselling and expanded reagent portfolios.

Growing Scientific Collaboration Partnerships with organizations like the International Society of Wildlife Endocrinology highlight their focus on collaborative research. Providing research tools, data management solutions, or custom assay development services could support their expansion into new scientific domains and funding avenues.

Market Expansion Potential With recent product launches and a focus on human and animal health biomarkers, Arbor Assays is positioned for growth in both clinical and research markets. Targeted outreach to academic, biotech, and pharmaceutical customers could unlock new sales channels.

Technology and Infrastructure Utilizing platforms like Shopify and hosting recent product launches online, the company shows digital engagement, creating opportunities to expand e-commerce capabilities, provide digital training tools, and integrate laboratory automation or data management solutions to enhance customer experience.